AGM
Alpine Global Management Portfolio holdings
AUM
$436M
1-Year Return
37.82%
This Quarter Return
-1.78%
1 Year Return
+37.82%
3 Year Return
+131.76%
5 Year Return
+262.91%
10 Year Return
+699.1%
AUM
$575M
AUM Growth
+$58.8M
(+11%)
Cap. Flow
+$68.6M
Cap. Flow
% of AUM
11.94%
Top 10 Holdings %
Top 10 Hldgs %
36.71%
Holding
556
New
357
Increased
46
Reduced
31
Closed
94
Top Buys
| 1 |
Strategy Inc Common Stock Class A
MSTR
|
$26.5M |
| 2 |
Microsoft
MSFT
|
$9.78M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$6.84M |
| 4 |
Archer Aviation
ACHR
|
$6.4M |
| 5 |
Applied Materials
AMAT
|
$5.47M |
Top Sells
| 1 |
AGTI
Agiliti, Inc.
AGTI
|
$26.4M |
| 2 |
Robinhood
HOOD
|
$22.7M |
| 3 |
CPE
Callon Petroleum Company
CPE
|
$17.7M |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
$11.7M |
| 5 |
CRH
CRH
|
$7.76M |
Sector Composition
| 1 | Healthcare | 17.25% |
| 2 | Technology | 14.7% |
| 3 | Financials | 8.94% |
| 4 | Industrials | 5.39% |
| 5 | Communication Services | 3.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Humacyte
HUMA
$226M
| $128K | 0.02% |
+26,744
| New | +$128K |
|
|
NAGE
352
Niagen Bioscience, Inc. Common Stock
NAGE
$750M
| $127K | 0.02% |
+46,363
| New | +$127K |
|
353
indie Semiconductor
INDI
$854M
| $126K | 0.02% |
+20,501
| New | +$126K |
|
354
eXp World Holdings
EXPI
$1.76B
| $126K | 0.02% |
+11,187
| New | +$126K |
|
355
Granite Ridge Resources
GRNT
$700M
| $125K | 0.02% |
+19,680
| New | +$125K |
|
356
Solid Biosciences
SLDB
$428M
| $124K | 0.02% |
+21,918
| New | +$124K |
|
357
BioCryst Pharmaceuticals
BCRX
$1.74B
| $124K | 0.02% |
+20,071
| New | +$124K |
|
|
GOEV
358
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $123K | 0.02% |
+2,898
| New | +$123K |
|
359
Kyverna Therapeutics
KYTX
$170M
| $121K | 0.02% |
+16,169
| New | +$121K |
|
360
Rush Street Interactive
RSI
$2.02B
| $121K | 0.02% |
+12,612
| New | +$121K |
|
361
Perma-Fix Environmental Services
PESI
$223M
| $121K | 0.02% |
+11,909
| New | +$121K |
|
362
FibroBiologics
FBLG
$24.1M
| $120K | 0.02% |
+24,092
| New | +$120K |
|
363
EyePoint Pharmaceuticals
EYPT
$966M
| $117K | 0.02% |
+13,471
| New | +$117K |
|
364
Candel Therapeutics
CADL
$274M
| $116K | 0.02% |
+18,761
| New | +$116K |
|
365
Capricor Therapeutics
CAPR
$308M
| $115K | 0.02% |
+24,168
| New | +$115K |
|
366
Cato Corp
CATO
$87.2M
| $115K | 0.02% |
+20,800
| New | +$115K |
|
367
Iovance Biotherapeutics
IOVA
$901M
| $113K | 0.02% |
+14,106
| New | +$113K |
|
368
Amicus Therapeutics
FOLD
$2.46B
| $112K | 0.02% |
+11,297
| New | +$112K |
|
369
1stdibs.com
DIBS
$100M
| $111K | 0.02% |
+24,761
| New | +$111K |
|
370
Everspin Technologies
MRAM
$147M
| $111K | 0.02% |
+18,536
| New | +$111K |
|
371
Geospace Technologies
GEOS
$231M
| $111K | 0.02% |
+12,323
| New | +$111K |
|
372
Blink Charging
BLNK
$117M
| $111K | 0.02% |
+40,356
| New | +$111K |
|
373
Porch Group
PRCH
$1.9B
| $110K | 0.02% |
73,097
+63,097
| +631% | +$95.3K |
|
374
Nuvation Bio
NUVB
$1.33B
| $110K | 0.02% |
+37,566
| New | +$110K |
|
375
Terns Pharmaceuticals
TERN
$632M
| $109K | 0.02% |
+16,078
| New | +$109K |
|